Cranial particulate bone graft ossifies calvarial defects by osteogenesis

Current understanding of bone graft healing includes both osteoconductive and osteoinductive mechanisms. Prior research has shown that bone grafts can provide structural support and release growth factors. However, the role of viable cells in grafts remains unclear. No prior work had resolved whether cell viability is essential for successful ossification. This gap motivated further investigation into the biological activity of particulate bone grafts. Studies have demonstrated that devitalized grafts may still promote healing through scaffold effects. Yet, the extent to which living cells contribute to healing is debated. This uncertainty drove the current study to isolate the role of osteoblasts in ossification. The need for clarity on osteogenic versus osteoconductive mechanisms is critical in surgical practice.

This study aimed to determine whether viable cells in particulate bone grafts are necessary for successful ossification. Specifically, the research tested the hypothesis that osteogenesis is the primary mechanism of healing in cranial defects. The study focused on comparing outcomes between viable and devitalized grafts. The motivation stemmed from clinical needs to optimize graft selection for cranial repair. By isolating the effect of cell viability, the researchers sought to clarify healing mechanisms. The study design allowed for direct comparison of ossification rates. The goal was to distinguish between osteogenic and osteoconductive contributions. This distinction is vital for surgical decision-making and graft material development.

The study used rabbit calvarial models to assess ossification in cranial defects. Three treatment groups were tested: no implant, viable particulate bone, and devitalized particulate bone. Resazurin assays measured metabolic activity in harvested bone samples. Alkaline phosphatase activity was used to detect viable osteoblasts in grafts. Micro-computed tomography quantified ossification after 16 weeks. Histological analysis confirmed ossification patterns in each group. The experimental design controlled for variables like defect size and implantation technique. The use of critical-size defects ensured that healing relied on graft material rather than spontaneous repair.

Particulate bone grafts showed significantly higher metabolic activity than devitalized grafts. Viable osteoblasts were detected in particulate bone but not in devitalized or dust samples. Alkaline phosphatase activity was 0.13 μU/μg in viable grafts versus 0.000 in devitalized grafts. Ossification rates were 99.7% in viable grafts compared to 42.2% in devitalized grafts. No significant difference was observed between devitalized grafts and the control group. Histological findings supported the micro-CT results in viable graft-treated defects. These data suggest that living cells are essential for maximal ossification. The results indicate that osteogenesis is the primary mechanism of healing in this model.

The study findings support the hypothesis that viable cells in particulate bone grafts are required for successful ossification. The data suggest that osteogenesis is the primary mechanism of healing in cranial defects. Devitalized grafts did not achieve significant ossification compared to controls. These results indicate that living osteoblasts are necessary for maximal healing outcomes. The study does not suggest that devitalized grafts are ineffective in all contexts. However, the evidence supports the importance of cell viability in this specific model. The authors propose that osteogenic potential is a key factor in graft selection. These conclusions are based on direct comparisons of ossification rates across treatment groups.